큐리옥스바이오시스템즈

445680 코스닥
50,600 11,650 (+29.91%)
기준 : 08/14
  • 시가총액
    6,701억
  • 주식수
    1,712만
  • PER
    -25.57배
  • PBR
    12.96배
  • ROE
    -50.66%
  • 결산월
    12월

26.2Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2026/06 2026/03 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09
매출액(수익) 5757.3 5555.5 5151.5 4242.5 3838.2
내수 N/AN/A 00.4 00.0 00.0 00.0
수출 N/AN/A 5555.1 5151.4 4242.5 3838.1
기타 N/AN/A 00.4 00.0 00.0 00.0
매출원가 N/AN/A 3434.6 3030.1 2525.0 2323.7
원재료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재고자산의변동 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타원가 N/AN/A 2121.9 1818.6 1313.0 1111.3
인건비 N/AN/A 2727.7 2727.8 2727.1 2727.2
감가상각비 N/AN/A 44.6 44.3 44.0 33.6
기타 N/AN/A -19-19.6 -20-20.5 -19-19.2 -18-18.4
매출총이익 N/AN/A 2020.8 2121.3 1717.5 1414.4
판매비와관리비 N/AN/A 146146.2 144144.5 150150.4 153153.1
급여 N/AN/A 5858.9 5858.2 5959.1 6161.1
퇴직급여 N/AN/A 00.6 00.6 00.6 00.5
복리후생비 N/AN/A 55.7 55.4 66.3 55.9
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
전산처리비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지급수수료 N/AN/A 77.8 77.5 66.8 77.7
용역비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 44.6 44.5 55.4 55.4
애프터서비스비 N/AN/A 0-0.2 0-0.8 11.5 22.4
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 2424.9 2626.1 2828.1 2929.0
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A 00.1 00.2 00.0 00.0
감가상각비 N/AN/A 44.3 55.2 66.1 66.6
무형자산상각비 N/AN/A 1212.2 1212.1 1111.9 1111.7
기타 N/AN/A 2727.0 2525.1 2424.2 2222.4
영업이익 -130-130.4 -125-125.4 -123-123.1 -132-132.9 -138-138.7
EBITDA N/AN/A -230-230.4 -238-238.0 -198-198.2 -208-208.3
금융손익 N/AN/A -132-132.9 -144-144.6 -93-93.9 -98-98.1
금융수익 N/AN/A 185185.0 182182.6 116116.6 113113.2
이자수익 N/AN/A 44.6 55.3 66.2 66.6
외환거래이익 N/AN/A 1010.5 77.4 2121.1 1717.3
외환차익 N/AN/A 22.2 11.6 44.3 77.0
외화환산이익 N/AN/A 88.3 55.7 1616.8 1010.3
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A 169169.7 169169.7 8989.2 8989.2
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 317317.9 327327.2 210210.5 211211.4
이자비용 N/AN/A 88.8 1111.8 1414.8 1515.4
외환거래손실 N/AN/A 44.1 88.2 1313.1 1919.1
외환차손 N/AN/A 11.3 44.9 77.8 99.0
외화환산손실 N/AN/A 22.8 33.3 55.2 1010.1
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A 299299.9 299299.9 173173.3 167167.0
기타 N/AN/A 44.9 77.0 99.2 99.8
기타영업외손익 N/AN/A -4-4.6 -5-5.5 -6-6.7 -6-6.8
기타영업외수익 N/AN/A 00.4 00.8 00.6 00.6
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A 00.0 00.0 00.0 00.0
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.4 00.7 00.6 00.6
기타영업외비용 N/AN/A 55.1 66.3 77.4 77.5
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 00.6 00.6 11.1 11.2
무형자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A 44.2 44.2 44.8 44.7
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.2 11.4 11.4 11.5
종속기업및관계기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A -263-263.0 -273-273.3 -233-233.6 -243-243.7
법인세비용 N/AN/A -1-1.0 -1-1.5 -1-1.1 -1-1.3
중단사업이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
당기순이익 -127-127.8 -262-262.0 -271-271.7 -232-232.4 -242-242.3
지배지분 순이익 N/AN/A -262-262.0 -271-271.7 -232-232.4 -242-242.3
비지배지분 순이익 N/AN/A 00.0 00.0 00.0 00.0
기타포괄이익 N/AN/A 2323.8 1414.2 1515.3 1515.2
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
해외사업환산손익 N/AN/A 2323.8 1414.2 1515.3 1515.2
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
총포괄이익 N/AN/A -238-238.1 -257-257.5 -217-217.1 -227-227.1
지배지분 총포괄이익 N/AN/A -238-238.1 -257-257.5 -217-217.1 -227-227.1
비지배지분 총포괄이익 N/AN/A 00.0 00.0 00.0 00.0
주당순이익 N/AN/A -1,599-1,599.0 -1,668-1,668.9 -1,433-1,433.1 -1,501-1,501.5
시가총액 N/AN/A 17,35917,359.5 20,03020,030.2 11,39211,392.3 6,2636,263.0
주가 N/AN/A 101,400101,400.0 117,000117,000.0 67,40067,400.0 38,75038,750.0
주가수익배수 N/AN/A -66.26-66.26 -73.70-73.70 -49.01-49.01 -25.84-25.84
주식수(만주) N/A 1,712 1,712 1,709 1,616 1,615 1,612 1,610 1,607 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄